MENU
VRNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Verona Pharma (VRNA) Earnings Date & Reports

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs... Show more

A.I. Advisor
published Earnings

VRNA is expected to report earnings to rise 33.40% to -6 cents per share on April 30

Verona Pharma VRNA Stock Earnings Reports
Q1'25
Est.
$-0.07
Q4'24
Beat
by $0.02
Q3'24
Est.
$-0.07
Q2'24
Missed
by $0.06
Q1'24
Missed
by $0.01
The last earnings report on February 27 showed earnings per share of -5 cents, beating the estimate of -7 cents. With 1.67M shares outstanding, the current market capitalization sits at 5.13B.
View a ticker or compare two or three
VRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a r&d company for the treatment of allergic rhinitis and other chronic respiratory diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
3 More London Riverside
Phone
+44 2032834200
Employees
79
Web
https://www.veronapharma.com